XORTX Therapeutics XRTX
NASDAQ XRTX
$0.93 -0.06 (-6.05%)
At close: Oct 21, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Debt Ratio (2022 - 2026)

Updated

XORTX Therapeutics' (XRTX) Debt Ratio stood at 0.01 in the quarter ended Mar 31, 2023, up 19.2% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Debt Ratio (2022 - 2026) Analysis & Trends

Starting with the quarter ended Jun 30, 2022, XORTX Therapeutics' Debt Ratio history includes 4 quarters.

  • Per Business Quant, the preceding three quarters came in at 0.01 (quarter ended Dec 31, 2022), 0.01 (quarter ended Sep 30, 2022) and 0.01 (quarter ended Jun 30, 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 XORTX Therapeutics 893,236.25 -2.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.01
Dec 31, 2025 -0.01
Sep 30, 2025 -0.02
Mar 31, 2025 0.00
Dec 31, 2023 0.00
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01
API Access

XORTX Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=XRTX&period=max&api_key=YOUR_API_KEY